Relevant bibliographies by topics / Pancreatic neuroendocrine tumour

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Pancreatic neuroendocrine tumour'

Author: Grafiati
Published: 11 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pancreatic neuroendocrine tumour.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pancreatic neuroendocrine tumour"

1

Durga, Kharidehal, Nandam Mohan Rao, and Byna Syam Sundara Rao. "Mixed Neuroendocrine - Non-Neuroendocrine Neoplasm (MiNEN) - A Rare Heterogenous Malignancy of the Pancreas." International Journal of Research and Review 10, no. 6 (2023): 306–10. http://dx.doi.org/10.52403/ijrr.20230637.

Full text
Abstract:
Introduction: Pancreatic mixed neuroendocrine non-neuroendocrine neoplasms are extremely rare tumours accounting for 0.5% of all the pancreatic malignancies and 5% of all pancreatic neuroendocrine neoplasms. These tumors are rarely diagnosed preoperatively and they have a poor prognosis. Pancreatic MiNEN is characterized by 2 malignant lesions adenocarcinoma and Neuroendocrine tumour with each constituent involving more than 30% of the tumour. We report a case of 57yr old male with dullaching abdominal pain radiating to back. CA 19-9 was mildly elevated. Other laboratory tests are within norma
APA, Harvard, Vancouver, ISO, and other styles
2

Maslin, D., B. Challis, and H. Simpson. "Metastatic pancreatic neuroendocrine tumour." QJM 109, no. 5 (2016): 355. http://dx.doi.org/10.1093/qjmed/hcw036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mormul, Agata, Emilia Włoszek, Julia Nowoszewska, et al. "Rare Non-Neuroendocrine Pancreatic Tumours." Cancers 15, no. 8 (2023): 2216. http://dx.doi.org/10.3390/cancers15082216.

Full text
Abstract:
The most common tumour of the pancreas is ductal adenocarcinoma (PDAC). It remains one of the most lethal non-neuroendocrine solid tumours despite the use of a multi-approach strategy. Other, less-common neoplasms, which are responsible for 15% of pancreatic lesions, differ in treatment and prognosis. Due to the low incidence rate, there is a lack of information about the rarest pancreatic tumours. In this review, we described six rare pancreatic tumours: intraductal papillary mucinous neoplasm (IPMN), mucinous cystadenoma (MCN), serous cystic neoplasm (SCN), acinar cell carcinoma (ACC), solid
APA, Harvard, Vancouver, ISO, and other styles
4

Ferrel, Benjamin, Jan Franko, and May C. Tee. "Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia." BMJ Case Reports 14, no. 4 (2021): e240786. http://dx.doi.org/10.1136/bcr-2020-240786.

Full text
Abstract:
An asymptomatic 68-year-old woman who presented with an isolated hypercalcaemia was diagnosed with a rare, previously unsuspected parathyroid hormone-related peptide (PTHrP)-producing pancreatic neuroendocrine tumour. She underwent an extensive operation including vascular resection and reconstruction, resulting in successful removal of the tumour with negative margins. Medical and surgical management of pancreatic neuroendocrine tumours and PTHrP-mediated paraneoplastic hypercalcaemia is discussed.
APA, Harvard, Vancouver, ISO, and other styles
5

Weerasuriya, Scott, Kieran Palmer, Stephen Gregory, Benjamin C. Whitelaw, Elisa Gonzalez, and Rajaventhan Srirajaskanthan. "Mesenteric Variceal Haemorrhage and Ectopic Cushing’s Syndrome as Presenting Features of a Pancreatic Neuroendocrine Tumour Recurrence." Case Reports in Gastroenterology 15, no. 3 (2021): 919–26. http://dx.doi.org/10.1159/000518021.

Full text
Abstract:
Pancreatic neuroendocrine tumours can have varied and complex presentations. Whilst hormone hypersecretion often induces characteristic clinical syndromes, non-specific symptoms may arise due to localized tumour effects. Malignant invasion of local vasculature is an increasingly recognized complication of these neoplasms and can be associated with significant morbidity. Herein, we present the case of a 47-year-old male with a recurrence of a pancreatic neuroendocrine tumour who presented with unusual upper gastrointestinal bleeding. The tumour had recurred within the superior mesenteric vein,
APA, Harvard, Vancouver, ISO, and other styles
6

Kann, P. H., E. Balakina, D. Ivan, et al. "Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study." Endocrine-Related Cancer 13, no. 4 (2006): 1195–202. http://dx.doi.org/10.1677/erc.1.01220.

Full text
Abstract:
Endoscopic ultrasound (EUS) enables detection and localization of pancreatic neuroendocrine tumours. Even small tumours down to a diameter of 1–2 mm can be visualized. Since such small tumours usually cannot be detected by computed tomography (ct), magnetic resonance imaging (mri) and somatostatin receptor scintigraphy (srs), and experience with EUS imaging is limited, there is no clear evidence for clinical management in multiple endocrine neoplasia type 1 (MEN1). Knowledge about the natural course of growth and metastatic distribution is mandatory to come to appropriate clinical decisions an
APA, Harvard, Vancouver, ISO, and other styles
7

Laccourreye, Ollivier, Eric Chabardes, Gregory Weinstein, Francoise Carnot, Daniel Brasnu, and Henri Laccourreye. "Synchronous arytenoid and pancreatic neuroendocrine carcinoma." Journal of Laryngology & Otology 105, no. 5 (1991): 373–75. http://dx.doi.org/10.1017/s0022215100116044.

Full text
Abstract:
AbstractNeuroendocrine laryngeal carcinoid tumours are uncommon. The supraglottis is the main location of these tumours. Eighty-one cases have been reported in the world literature. We present the first case of a synchronous laryngeal and pancreatic neuroendocrine tumour.
APA, Harvard, Vancouver, ISO, and other styles
8

Venugopal, Abhirami, Agnes Michalczyk, Mustafa Khasraw, and M. Leigh Ackland. "EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms." International Journal of Molecular Sciences 23, no. 21 (2022): 13645. http://dx.doi.org/10.3390/ijms232113645.

Full text
Abstract:
Neuroendocrine neoplasms (NENs) are relatively rare neoplasms occurring predominantly in the gastrointestinal tract and pancreas. Their heterogeneity poses challenges for diagnosis and treatment. There is a paucity of markers for characterisation of NEN tumours. For routine diagnosis, immunohistochemistry of the NEN-specific markers CgA and synaptophysin and the proliferation marker Ki-67 are used. These parameters, however, are qualitative and lack the capacity to fully define the tumour phenotype. Molecules of epithelial–mesenchymal transition (EMT) are potential candidates for improved tumo
APA, Harvard, Vancouver, ISO, and other styles
9

Bertani, Helga, Alessandro Messerotti, Fabrizio Di Benedetto, et al. "Unusual Paraneoplastic Syndrome Accompanies Neuroendocrine Tumours of the Pancreas." Case Reports in Medicine 2011 (2011): 1–4. http://dx.doi.org/10.1155/2011/309149.

Full text
Abstract:
Neuroendocrine tumours comprise a small percentage of pancreatic neoplasia (10%) (1). Diagnosis of neuroendocrine tumours is difficult, especially if the tumours are small and nonfunctional. CT scans, MRI, and nuclear scans are sufficiently sensitive assessment tools for tumours with diameters of at least 2 cm; otherwise, the sensitivity and specificity of these techniques is less than 50% (2). Myasthenia gravis (MG) is a heterogeneous neuromuscular junction disorder that is primarily caused when antibodies form against the acetylcholine receptors (Ab-AchR). MG can develop in conjunction with
APA, Harvard, Vancouver, ISO, and other styles
10

Lines, K. E., R. P. Vas Nunes, M. Frost, C. J. Yates, M. Stevenson, and R. V. Thakker. "A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control." Endocrine Connections 6, no. 4 (2017): 232–42. http://dx.doi.org/10.1530/ec-17-0040.

Full text
Abstract:
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by occurrence of parathyroid tumours and neuroendocrine tumours (NETs) of the pancreatic islets and anterior pituitary. The MEN1 gene, encoding menin, is a tumour suppressor, but its precise role in initiating in vivo tumourigenesis remains to be elucidated. The availability of a temporally controlled conditional MEN1 mouse model would greatly facilitate the study of such early tumourigenic events, and overcome the limitations of other MEN1 knockout models, in which menin is lost from conception or tumou
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pancreatic neuroendocrine tumour"

1

Gill, Preetjote. "Studies In Patients With Surgically Resected Pancreatic Neuroendocrine Tumours - MicroRNA Expression And Clinical Correlation." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/18181.

Full text
Abstract:
INTRODUCTION Pancreatic Neuroendocrine Tumours (PNETS) have increased in incidence over the past three decades. Treatment options currently include surgery, locoregional and systemic therapies, however the prognosis remains poor and biomarkers that accurately predict the clinical behavior of these tumours are lacking. Dysregulation of microRNAs (miRNAs) has recently been shown to play a role in the development of many cancers through post-transcriptional gene regulation, however, few studies have investigated the role of miRNAs as diagnostic or prognostic markers in PNETs. METHODS Patients un
APA, Harvard, Vancouver, ISO, and other styles
2

De, Cassan Chiara. "Elastography mean strain histogram value for the differential diagnosis of malignant pancreatic masses: a monocentric study." Doctoral thesis, Università degli studi di Padova, 2016. http://hdl.handle.net/11577/3424524.

Full text
Abstract:
Introduction Endoscopic ultrasound (EUS) elastography is a recent ultrasound method used for the real-time visualization and evaluation of tissue elasticity. Qualitative and quantitative methods have been used, in particular in evaluation of pancreatic diseases and malignant lymph nodes, with interesting results regarding the accuracy and the differential diagnosis between malignant and benign masses. No consensus has been reached with regard to the superiority of different quantitative methods, but strain ratio and strain histogram (SH) remain the most used. SH corresponds to a graphical re
APA, Harvard, Vancouver, ISO, and other styles
3

Hanson, Matthew Richard. "Expression studies on PPARγ in pancreatic neuroendocrine tumours". Thesis, Queen Mary, University of London, 2010. http://qmro.qmul.ac.uk/xmlui/handle/123456789/710.

Full text
Abstract:
Pancreatic NETs occur with an annual incidence of around 5 per 1,000,000 population per year, with survival rates of between 30 – 97% at 5 years depending on the tumour subtype. The PPARs (peroxisomal proliferator-activated receptors) are members of the nuclear receptor superfamily that includes receptors for thyroid, steroid and retinoid hormones. PPARγ protein is also thought to be expressed in human pancreatic islet cells and has been shown to be a negative regulator of islet β cell mass both in vivo and in vitro. Its emerging function in controlling cell proliferation, differentiation and
APA, Harvard, Vancouver, ISO, and other styles
4

Bösch, Florian [Verfasser], and Markus [Akademischer Betreuer] Guba. "Single center experience in pancreatic neuroendocrine tumors / Florian Bösch. Betreuer: Markus Guba." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2015. http://d-nb.info/1081899859/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yamauchi, Yuki. "Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/264634.

Full text
Abstract:
京都大学<br>新制・論文博士<br>博士(医学)<br>乙第13418号<br>論医博第2226号<br>新制||医||1052(附属図書館)<br>京都大学大学院医学研究科医学専攻<br>(主査)教授 羽賀 博典, 教授 長船 健二, 教授 伊藤 貴浩<br>学位規則第4条第2項該当<br>Doctor of Medical Science<br>Kyoto University<br>DFAM
APA, Harvard, Vancouver, ISO, and other styles
6

Körner, Jan Lennart [Verfasser], and Roland [Akademischer Betreuer] Kontermann. "Target identification and probe development for pancreatic neuroendocrine tumors / Jan Lennart Körner. Betreuer: Roland Kontermann." Stuttgart : Universitätsbibliothek der Universität Stuttgart, 2015. http://d-nb.info/1069290211/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

ANDREASI, VALENTINA. "ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS." Doctoral thesis, Università Vita-Salute San Raffaele, 2021. http://hdl.handle.net/20.500.11768/121777.

Full text
Abstract:
Introduction: The lack of valid biomarkers represents a major unmet clinical need in pancreatic neuroendocrine neoplasms (PanNENs). Chromogranin A (CgA) is the most commonly measured PanNEN biomarker, despite relevant limitations related to variable sensitivity, poor specificity and lack of assay standardization. Therefore, novel biomarkers are needed to improve diagnosis, detect disease recurrence and assess treatment response. In this project, the role of CgA-derived fragments as PanNEN biomarkers was investigated, focusing on the N-terminal peptide vasostatin-1 (VS-1). A multianalyte biomar
APA, Harvard, Vancouver, ISO, and other styles
8

Örlefors, Håkan. "Positron Emission Tomography in the Management of Neuroendocrine Tumors." Doctoral thesis, Uppsala University, Department of Medical Sciences, 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3356.

Full text
Abstract:
<p>Neuroendocrine tumors (NET´s) are often characterized by overproduction of peptide hormones. In spite of pronounced clinical symptoms, the tumor lesions can be small and difficult to detect. The general aim of this thesis was to investigate, in vitro and in vivo, some of the potential monoamine pathways present in NET´s, using radiolabeled tracers for positron emission tomography (PET), with the intention to explore the value of PET-imaging in the management of NET´s.</p><p>We used the 11C-labeled serotonin precursor 5-hydroxy tryptophan (HTP) as the tracer for imaging of NET´s. More than 9
APA, Harvard, Vancouver, ISO, and other styles
9

Capodanno, Ylenia. "Identifying therapeutic implications of cancer stem cells in human and canine insulinoma." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/31175.

Full text
Abstract:
Pancreatic neuroendocrine tumours (PNETs) are the most common neuroendocrine tumours diagnosed in humans and dogs. Due to the highly heterogeneous nature of these tumours, definitive data are still lacking over the molecular mechanisms involved in their cancerous behaviour. This study focused on insulinoma (INS), as it is the most commonly diagnosed PNET in human and veterinary oncology. INS is an insulin-producing tumour that causes a hypoglycaemic syndrome related to the excessive insulin production. In humans, it is often a small benign neoplasm readily curable by surgical resection whereas
APA, Harvard, Vancouver, ISO, and other styles
10

Ekeblad, Sara. "Pancreatic Endocrine Tumors and GIST - Clinical Markers, Epidemiology and Treatment." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7937.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pancreatic neuroendocrine tumour"

1

Pisegna, Joseph R., ed. Management of Pancreatic Neuroendocrine Tumors. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1798-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khayat, Eric. Tumeurs neuroendocrines digestives et médecine nucléaire. Editions médicales internationales, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bertram, Wiedenmann, ed. Molecular and cell biological aspects of gastroenteropancreatic neuroendocrine tumor disease. New York Academy of Sciences, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Carton, James. Pancreatic pathology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759584.003.0009.

Full text
Abstract:
This chapter discusses pancreatic pathology and covers pancreatic malformations, acute pancreatitis, chronic pancreatitis, pancreatic ductal carcinoma, pancreatic neuroendocrine tumours, pancreatic cystic tumours, and acinar cell carcinoma.
APA, Harvard, Vancouver, ISO, and other styles
5

Pisegna, Joseph R. Management of Pancreatic Neuroendocrine Tumors. Springer New York, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pisegna, Joseph R. Management of Pancreatic Neuroendocrine Tumors. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pisegna, Joseph R. Management of Pancreatic Neuroendocrine Tumors. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pancreatic Cancer Cystic and Endocrine Neoplasm. John Wiley and Sons Ltd, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Howe, James R. Management of GI and Pancreatic Neuroendocrine Tumors,an Issue of Surgical Oncology Clinics of North America. Elsevier, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pancreatic neuroendocrine tumour"

1

Koumarianou, Anna, and Nicola Fazio. "Nonfunctioning Pancreatic Neuroendocrine Tumors." In Neuroendocrine Tumours. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45215-8_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fazio, Nicola, and Anna Koumarianou. "Non-Functioning Pancreatic Neuroendocrine Tumors." In Neuroendocrine Tumours. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-56968-5_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Komminoth, Paul. "Somatostatin-Producing Tumor." In Pancreatic Neuroendocrine Neoplasms. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17235-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Uccella, Silvia, Roberta Maragliano, and Francesca Magnoli. "ACTH-Producing Tumor." In Pancreatic Neuroendocrine Neoplasms. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17235-4_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

La Rosa, Stefano, Nora Sahnane, and Laura Cimetti. "Serotonin-Producing Tumor." In Pancreatic Neuroendocrine Neoplasms. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17235-4_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chew, C., and G. K. Bonney. "Pancreatic Neuroendocrine Tumours." In Evidence-Based Endocrine Surgery. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-1124-5_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tamburrino, Domenico, Stefano Partelli, and Massimo Falconi. "Pancreatic Neuroendocrine Tumours." In Surgical Diseases of the Pancreas and Biliary Tree. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8755-4_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Johnson, Paul R. V. "Pancreatic Neuroendocrine Tumours." In Endocrine Surgery in Children. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-54256-9_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bennett, Sean Alexander, Calvin How Lim Law, Angela Assal, Sten Myrehaug, and Julie Hallet. "Functional Pancreatic Neuroendocrine Tumors." In Neuroendocrine Tumors. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62241-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Park, Young Suk. "Less Common Types of Pancreatic Neuroendocrine Tumors." In Neuroendocrine Tumours. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45215-8_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pancreatic neuroendocrine tumour"

1

Souto, Andreza Karine de Barros Almeida, Poliana Bergamaschine Giovani Blasi, Brenda Fabiola Delgado Taboada, Fernanda Teresa Lima, Bernardo Garicochea, and Cristiano Augusto Andrade de Resende. "NEUROENDOCRINE CARCINOMA OF THE BREAST AND ILEUM IN A PATIENT WITH BRCA2 PATHOGENIC VARIANT – ONCOLOGIC AND GENETIC CONSIDERATIONS DERIVED FROM A CASE REPORT." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2076.

Full text
Abstract:
Background: Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplasms. Most frequently, they occur in the digestive system, and breast neuroendocrine tumors constitute less than 1% of all of them. Germline mutations can increase the risk of developing tumors and predispose to hereditary cancer syndromes. Some NENs are well-established components of common hereditary syndromes. Recently, whole genomic sequencing revealed that 17% of apparently sporadic pancreatic NENs carried germline mutations, including DNA repair genes, such as BRCAs. It is well known that this gene plays a role
APA, Harvard, Vancouver, ISO, and other styles
2

Arnez, Marco Antonio Cuellar, Leonardo Brasileiro Marques, Ana Livia Felipe Dias, Gabrielle Gadelha Costa, Gustavo Lopes Teixeira, and Alexandre de Medeiros Silva. "PANCREATIC NEUROENDOCRINE TUMOR MIMICKING IMMUNOGLOBULIN G4-RELATED DISEASE." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.2643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Simon, T., S. Mamlouk, S. Khouja, et al. "PO-329 Genomic aberration in pancreatic neuroendocrine tumours (PNET)." In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.359.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhu, Zhuotun, Yongyi Lu, Wei Shen, Elliot K. Fishman, and Alan L. Yuille. "Segmentation for Classification of Screening Pancreatic Neuroendocrine Tumors." In 2021 IEEE/CVF International Conference on Computer Vision Workshops (ICCVW). IEEE, 2021. http://dx.doi.org/10.1109/iccvw54120.2021.00379.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Witt, D., B. L. Levarge, and F. B. Askin. "Unilateral Pulmonary Tumor Emboli And Lymphangitic Carcinomatosis From Pancreatic Neuroendocrine Tumor." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mpilla, Gabriel B., Amro Aboukameel, Md Hafiz Uddin, et al. "Abstract 1122: Novel targets for therapy resistant pancreatic neuroendocrine tumors." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cazacu, IM, IF Cherciu Harbiyeli, A. Constantin, et al. "Hypervascular Pancreatic Lesions on Contrast-Enhanced EUS: Beyond Neuroendocrine Tumors." In ESGE Days 2021. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1724433.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Huang, Jingzhi, Xiaohua Xie, Manxia Lin, Ming Xu, Guangliang Huang, and Xiaoyan Xie. "IDDF2020-ABS-0041 Pancreatic neuroendocrine tumors: correlation between the sonographic features and the pathological tumor grade." In Abstracts of the International Digestive Disease Forum (IDDF), 22–23 November 2020, Hong Kong. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2020. http://dx.doi.org/10.1136/gutjnl-2020-iddf.49.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Contractor, Tanupriya, Chang Chan, Shinta Kobayashi, et al. "Abstract 3185: Complement C5 promotes male bias of pancreatic neuroendocrine tumor metastasis." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Maeng, Kyungah, Hye Seung Lee, Min Chen, and Maria Zajac-Kaye. "Abstract 3922: Deregulated thymidylate synthase promotes tumorigenecity in pancreatic neuroendocrine tumors." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3922.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pancreatic neuroendocrine tumour' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography